granisetron
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics
Conditions
Pharmacokinetics
Trial Timeline
Apr 1, 2009 → Sep 1, 2009
NCT ID
NCT00868764About granisetron
granisetron is a phase 1 stage product being developed by Kyowa Kirin for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT00868764. Target conditions include Pharmacokinetics.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04501211 | Phase 2 | Withdrawn |
| NCT00890565 | Phase 1 | Completed |
| NCT00868764 | Phase 1 | Completed |
| NCT00873197 | Phase 1 | Completed |
| NCT00273468 | Phase 3 | Completed |
Competing Products
20 competing products in Pharmacokinetics